Department of
medical microbiology, UGMS

The Department’s research thrives on three fundamental principles: innovation, collaboration and impact

Research in the Department of Medical Microbiology is vibrant. This stems from our extensive local and international collaborations as well as faculty of the Department attracting research grants. Over the years, our research projects have been funded by institutions such as DANIDA, UK Department of Health, NIH, WHO, GAVI, Pfizer Pharmaceuticals and Alborada Fund. The Department’s research covers a wide scope of microbial pathogens: Staphylococcus aureus (including MRSA), Streptococcus pneumoniae, Vibrio cholerae, Escherichia coli, Klebsiella pneumoniae, Salmonella spp., Rotavirus, Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Coronaviruses, Candida spp., Cryptococcus neoformans, Plasmodium spp., Schistosoma heamatobium, Babesia spp. and Entamoeba spp. We also carry out research on vectors of some of these microbial pathogens. The Department has an extensive research programme on antimicrobial resistance (AMR), which covers the different types of microbes- bacteria, viruses, fungi and parasites. Recently, our AMR research received a major boost through the award of the Fleming Fund Country Grant of about £2.5 Million. As the primary host of this grant, the Department provides leadership in AMR research and surveillance in Ghana.


The Department of Medical Microbiology currently hosts the National AMR Reference Laboratory, and this is a great opportunity to contribute to addressing the AMR menace.